Candel Therapeutics reduces stockholder meeting quorum threshold to one-third

Candel Therapeutics, Inc.

Board approved amendment to bylaws, effective May 29, 2024.
Quorum requirement lowered from majority to one-third of shares entitled to vote.
Amendment applies to all stockholder meetings of Candel Therapeutics, Inc.

item 5.03 item 9.01

Candel Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-066608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.